Company has filed a patent application for a proprietary primer set, diagnostic method and reaction mixture composition for genetic diagnosis of Salmonella enterica infections using the LAMP technique. The application was filed with the Patent Office of the Republic of Poland. The detection technology developed by Genomtec is faster and less expensive than those currently used on the market.
Salmonellosis or food poisoning is one of the most common infectious diseases – in both humans and animals. Animals and animal products are considered as a major source of Salmonella. All Salmonella infections begin with ingestion with contaminated food, milk or water and in humans can present as acute gastroenteritis, enteric fever (typhoid fever or paradurium) or bacteremia with or without clinical signs. The vast majority of human cases of salmonellosis disease is caused by bacteria belonging to the species Salmonella enterica, which would be now possible to detect through fast and cheaper testing method with the Genomtec® Salmonella Laboratory Kit.
– Applying for patent protection is due to significantly improved diagnostic parameters of our solutions in the area of molecular biology. Moreover, they are characterized by a shorter time needed to obtain a result, which is crucial where fast and very precise diagnostics is required. – said Miron Tokarski, CEO and co-founder of Genomtec.
Patent protection of the technology or processes constituting the given technology is a key area of building and safeguarding the intellectual value developed by Genomtec. Company’s technology is being ringfenced by securing ever-increasing number of patents and patent applications for the Genomtec ID diagnostic platform as well as in the space of molecular biology such as this filled application.
